↓ Skip to main content

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

Overview of attention for article published in BMC Cancer, January 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Published in
BMC Cancer, January 2019
DOI 10.1186/s12885-019-5297-x
Pubmed ID
Authors

Jeremie Calais, Johannes Czernin, Wolfgang P. Fendler, David Elashoff, Nicholas G. Nickols

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 43 61%
Researcher 7 10%
Other 4 6%
Student > Ph. D. Student 3 4%
Student > Master 3 4%
Other 4 6%
Unknown 7 10%
Readers by discipline Count As %
Unspecified 43 61%
Medicine and Dentistry 15 21%
Engineering 2 3%
Chemistry 2 3%
Immunology and Microbiology 1 1%
Other 1 1%
Unknown 7 10%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2021.
All research outputs
#7,068,833
of 23,124,001 outputs
Outputs from BMC Cancer
#1,864
of 8,394 outputs
Outputs of similar age
#147,755
of 438,146 outputs
Outputs of similar age from BMC Cancer
#44
of 163 outputs
Altmetric has tracked 23,124,001 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 8,394 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,146 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 163 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.